Personal tools

MCL coexpression mm9:701: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 6: Line 6:
|ontology_enrichment_disease=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0004177!5.80e-20!29;UBERON:0005057!5.80e-20!29;UBERON:0002193!6.85e-16!48;UBERON:0002405!6.85e-16!48;UBERON:0002390!7.77e-16!45;UBERON:0003061!7.77e-16!45;UBERON:0002370!1.58e-15!23;UBERON:0000974!1.58e-15!23;UBERON:0004807!1.58e-15!23;UBERON:0005058!1.58e-15!23;UBERON:0003351!1.58e-15!23;UBERON:0009113!1.58e-15!23;UBERON:0003295!1.58e-15!23;UBERON:0009722!1.58e-15!23;UBERON:0005562!1.58e-15!23;UBERON:0007690!1.58e-15!23;UBERON:0000077!2.06e-15!35;UBERON:0006562!1.13e-14!24;UBERON:0003408!1.13e-14!24;UBERON:0001557!1.13e-14!24;UBERON:0001042!1.13e-14!24;UBERON:0008814!1.13e-14!24;UBERON:0009145!1.13e-14!24;UBERON:0000072!1.71e-12!27;UBERON:0000065!1.47e-09!41;UBERON:0001004!3.34e-09!42;UBERON:0000063!1.47e-08!35;UBERON:0003081!3.07e-08!87;UBERON:0007811!3.40e-08!36;UBERON:0001041!7.02e-07!80
|ontology_enrichment_uberon=UBERON:0004177!5.80e-20!29;UBERON:0005057!5.80e-20!29;UBERON:0002193!6.85e-16!48;UBERON:0002405!6.85e-16!48;UBERON:0002390!7.77e-16!45;UBERON:0003061!7.77e-16!45;UBERON:0002370!1.58e-15!23;UBERON:0000974!1.58e-15!23;UBERON:0004807!1.58e-15!23;UBERON:0005058!1.58e-15!23;UBERON:0003351!1.58e-15!23;UBERON:0009113!1.58e-15!23;UBERON:0003295!1.58e-15!23;UBERON:0009722!1.58e-15!23;UBERON:0005562!1.58e-15!23;UBERON:0007690!1.58e-15!23;UBERON:0000077!2.06e-15!35;UBERON:0006562!1.13e-14!24;UBERON:0003408!1.13e-14!24;UBERON:0001557!1.13e-14!24;UBERON:0001042!1.13e-14!24;UBERON:0008814!1.13e-14!24;UBERON:0009145!1.13e-14!24;UBERON:0000072!1.71e-12!27;UBERON:0000065!1.47e-09!41;UBERON:0001004!3.34e-09!42;UBERON:0000063!1.47e-08!35;UBERON:0003081!3.07e-08!87;UBERON:0007811!3.40e-08!36;UBERON:0001041!7.02e-07!80
|tfbs_overrepresentation_for_novel_motifs=0.321524,0.0145773,0.807108,0.945937,0.580303,0.373426,0.458558,0.785038,0.131493,0.255527,0.417132,0.447169,0.124608,0.470194,0.613681,0,0.656089,0.564478,0.113609,0.451901,0.26524,0.336916,0.469335,0.198877,0.304728,0.496413,0.709649,0.392919,0.238759,0.0790295,0.379806,0.754912,0.191698,0.31333,0.214608,0.386349,0.184038,0.443753,0.498354,0.143746,0.196807,0.38461,0.0320468,0.617704,0.119503,0.349801,0.578773,0.407653,0.772185,0.241306,0.639101,0.522137,0.259389,0.894161,0.911367,0.47699,0.695271,0.435119,0.332535,0.47505,0.735292,0.531188,0.140453,0.628155,0.487593,0.667546,1.04613,1.3932,0.730718,1.24673,0.281085,0.80439,0.03967,0.944464,0.320434,0.0893951,0.313198,0.567793,0.718494,0.268962,0.80832,0.673009,0.529804,0.380754,0.830765,0.0593483,1.64605,2.60013,0.583509,1.55487,1.11522,0.835661,0.767462,0.205117,0.163126,0.892226,0.388243,0.770215,0.57902,0.234357,0.184103,0.754637,0.87698,0.639679,0.638654,0.3842,0.696857,0.403887,0.273261,0.736223,0.315128,0.878738,0.743427,0.421988,1.12221,0.5687,0.0187247,0.363536,0.657356,0.534159,0.949798,0.607824,1.24551,0.566919,1.17594,0.722111,0.466292,0.760818,1.04463,0.207624,0.86025,0.931072,1.01535,0.48999,1.14365,0.142597,0.329172,0.385921,1.09487,1.92247,1.5231,1.0508,0.509663,0.765172,0.632358,0.385031,0.581788,1.88287,0.331322,0.201635,0.0806411,0.0316649,0.895708,0.46758,0.489108,0.976367,1.29867,0.224422,0.319291,0.328917,1.1043,0.829923,0.722546,0.313083,0.629147,1.21106,0.18312,0.445669,0.0896551
}}
}}

Revision as of 18:46, 26 November 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr11:116220606..116220663,-p4@Rnf157
Mm9::chr16:48594718..48594733,+p@chr16:48594718..48594733
+
Mm9::chr1:139794954..139794996,-p@chr1:139794954..139794996
-
Mm9::chr1:162239217..162239246,-p2@Rabgap1l
Mm9::chr2:130365146..130365160,+p@chr2:130365146..130365160
+
Mm9::chr2:130365165..130365174,+p@chr2:130365165..130365174
+
Mm9::chr6:41005862..41005892,+p1@uc009bnr.2
Mm9::chr8:35170870..35170896,-p4@Dctn6
Mm9::chr9:123676335..123676359,+p1@Ccr9
Mm9::chr9:123690718..123690739,+p@chr9:123690718..123690739
+


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


no results for this coexpression

Relative expression of the co-expression cluster over median <br>Analyst:





Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br><br>uberon_data<br><br>


Uber Anatomy
Ontology termp-valuen
hemopoietic organ5.80e-2029
immune organ5.80e-2029
hemolymphoid system6.85e-1648
immune system6.85e-1648
hematopoietic system7.77e-1645
blood island7.77e-1645
thymus1.58e-1523
neck1.58e-1523
respiratory system epithelium1.58e-1523
hemolymphoid system gland1.58e-1523
pharyngeal epithelium1.58e-1523
thymic region1.58e-1523
pharyngeal gland1.58e-1523
entire pharyngeal arch endoderm1.58e-1523
thymus primordium1.58e-1523
early pharyngeal endoderm1.58e-1523
mixed endoderm/mesoderm-derived structure2.06e-1535
pharynx1.13e-1424
gland of gut1.13e-1424
upper respiratory tract1.13e-1424
chordate pharynx1.13e-1424
pharyngeal arch system1.13e-1424
pharyngeal region of foregut1.13e-1424
segment of respiratory tract1.71e-1227
respiratory tract1.47e-0941
respiratory system3.34e-0942
organ segment1.47e-0835
lateral plate mesoderm3.07e-0887
craniocervical region3.40e-0836
foregut7.02e-0780


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}